MAPT and Alzheimer disease: Our findings clearly indicated that higher baseline BMI was associated with higher levels of CSF Aβ42, lower t-tau and t-tau/Aβ42, lower load of Aβ, as well as larger brain volumes of AD-vulnerable regions.